ServiceNow's revenue and expenses in Q4 2024 are not available in the provided data. However, we can analyze the trends of its business composition, revenue by business, operating expenses, and net income to understand its financial performance.
- Business Composition: ServiceNow's business composition includes Plasma-Derived Therapies and Immunology1.
- Revenue by Business: The company generated a total revenue of $271.4 billion, with specific revenues from different business segments not provided separately1.
- Operating Expenses: ServiceNow's operating expenses were $592.36 million1.
- Net Income: The company reported a net income of $592.36 million1.
In conclusion, ServiceNow's revenue and expenses in Q4 2024 were substantial, with a significant revenue of $271.4 billion and operating expenses of $592.36 million, resulting in a net income of $592.36 million. The lack of detailed business segment revenue and expense data prevents a more nuanced analysis, but the overall financial performance was strong.